- Home
- UGRO vs EVAX Comparison
UGRO vs EVAX Comparison
Compare UGRO & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGRO
- EVAX
- Stock Information
- Founded
- UGRO 2014
- EVAX 2008
- Country
- UGRO United States
- EVAX Denmark
- Employees
- UGRO N/A
- EVAX N/A
- Industry
- UGRO Industrial Specialties
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UGRO Consumer Discretionary
- EVAX Health Care
- Exchange
- UGRO Nasdaq
- EVAX Nasdaq
- Market Cap
- UGRO 3.8M
- EVAX 17.8M
- IPO Year
- UGRO N/A
- EVAX 2021
- Fundamental
- Price
- UGRO $0.60
- EVAX $2.93
- Analyst Decision
- UGRO Strong Buy
- EVAX Strong Buy
- Analyst Count
- UGRO 1
- EVAX 2
- Target Price
- UGRO $3.00
- EVAX $10.00
- AVG Volume (30 Days)
- UGRO 14.7M
- EVAX 68.5K
- Earning Date
- UGRO 10-30-2025
- EVAX 10-30-2025
- Dividend Yield
- UGRO N/A
- EVAX N/A
- EPS Growth
- UGRO N/A
- EVAX N/A
- EPS
- UGRO N/A
- EVAX N/A
- Revenue
- UGRO $59,985,138.00
- EVAX $3,176,000.00
- Revenue This Year
- UGRO N/A
- EVAX N/A
- Revenue Next Year
- UGRO $31.25
- EVAX $425.50
- P/E Ratio
- UGRO N/A
- EVAX N/A
- Revenue Growth
- UGRO N/A
- EVAX 1042.45
- 52 Week Low
- UGRO $0.26
- EVAX $1.20
- 52 Week High
- UGRO $1.92
- EVAX $16.69
- Technical
- Relative Strength Index (RSI)
- UGRO 62.04
- EVAX 51.89
- Support Level
- UGRO $0.57
- EVAX $2.81
- Resistance Level
- UGRO $0.64
- EVAX $3.04
- Average True Range (ATR)
- UGRO 0.09
- EVAX 0.21
- MACD
- UGRO 0.01
- EVAX -0.00
- Stochastic Oscillator
- UGRO 51.35
- EVAX 68.64
About UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.